| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2141462 | Lung Cancer | 2012 | 6 Pages |
Abstract
In this hypothesis-generating study we identified multiple pre-treatment PET-CT metrics as potential predictors of OS and CSS in patients with NSCLC treated with SABR. These could aid risk-stratification and treatment individualization if validated prospectively.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jonathan A. Abelson, James D. Murphy, Nicholas Trakul, Jose G. Bazan, Peter G. Maxim, Edward E. Graves, Andrew Quon, Quynh-Thu Le, Maximilian Diehn, Billy W. Jr.,